摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-fluoro-2,3-dihydrobenzo[b]thiophen-7-ol | 693220-48-3

中文名称
——
中文别名
——
英文名称
4-fluoro-2,3-dihydrobenzo[b]thiophen-7-ol
英文别名
4-fluoro-2,3-dihydrobenzo[b]thiophene-7-ol;4-fluoro-2,3-dihydro-1-benzothiophen-7-ol
4-fluoro-2,3-dihydrobenzo[b]thiophen-7-ol化学式
CAS
693220-48-3
化学式
C8H7FOS
mdl
——
分子量
170.207
InChiKey
QEVWTHPRYBXSJM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.2
  • 重原子数:
    11
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    45.5
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (R)-3-iodo-1-phenyl-1-propanol4-fluoro-2,3-dihydrobenzo[b]thiophen-7-ol 以to give 242 mg of the title compound as a colorless solid的产率得到(1S)-4-fluoro-7-(3-iodo-1-phenyl-propoxy)-2,3-dihydrobenzo[b]thiophene
    参考文献:
    名称:
    Propanamine derivatives as serotonin and norepinephrine reuptake inhibitors
    摘要:
    提供了一种公式(I)的取代为3-氨基丙烷基的苄氧基/硫代苄氧基化合物,其中A选择自—O—和—S—; X选择自苯基,该苯基可选地被最多5个取代基取代,每个取代基独立地选择自卤素,C1-C4烷基和C1-C4烷氧基,噻吩基,该噻吩基可选地被最多3个取代基取代,每个取代基独立地选择自卤素和C1-C4烷基,以及C2-C8烷基,C2-C8烯基,C3-C8环烷基和C4-C8环烷基烷基,每个基团可选地被最多3个取代基取代,每个取代基独立地选择自卤素,C1-C4烷基,C1-C4烷氧基,C1-C4烷基—S(O)n—,其中n为0,1或2,—CF3,—CN和—CONH2; Y选择自二氢苯并噻吩基,苯并噻唑基,苯并异噻唑基,喹啉基,异喹啉基,萘啉基和噻吩吡啶基,每个基团可选地被最多4个或在可能情况下最多5个取代基取代,每个取代基独立地选择自卤素,C1-C4烷基,C1-C4烷氧基,C1-C4烷基-S(O)n—,其中n为0,1或2,硝基,乙酰基,—CF3,—SCF3和氰基; Z选择自H,OR3或F,其中R3选择自H,C1-C6烷基和苯基C1C6烷基; R1和R2各自独立地选择自H或C1-C4烷基;以及其药学上可接受的盐。
    公开号:
    US07410982B2
  • 作为产物:
    描述:
    三溴化硼4-fluoro-7-methoxy-2,3-dihydrobenzo[b]thiophene4-苯并噻唑 在 Mg 作用下, 以affords the title compound as a brown solid 251 Mg的产率得到4-fluoro-2,3-dihydrobenzo[b]thiophen-7-ol
    参考文献:
    名称:
    Propanamine derivatives as serotonin and norepinephrine reuptake inhibitors
    摘要:
    提供了一种公式(I)的取代为3-氨基丙烷基的苄氧基/硫代苄氧基化合物,其中A选择自—O—和—S—; X选择自苯基,该苯基可选地被最多5个取代基取代,每个取代基独立地选择自卤素,C1-C4烷基和C1-C4烷氧基,噻吩基,该噻吩基可选地被最多3个取代基取代,每个取代基独立地选择自卤素和C1-C4烷基,以及C2-C8烷基,C2-C8烯基,C3-C8环烷基和C4-C8环烷基烷基,每个基团可选地被最多3个取代基取代,每个取代基独立地选择自卤素,C1-C4烷基,C1-C4烷氧基,C1-C4烷基—S(O)n—,其中n为0,1或2,—CF3,—CN和—CONH2; Y选择自二氢苯并噻吩基,苯并噻唑基,苯并异噻唑基,喹啉基,异喹啉基,萘啉基和噻吩吡啶基,每个基团可选地被最多4个或在可能情况下最多5个取代基取代,每个取代基独立地选择自卤素,C1-C4烷基,C1-C4烷氧基,C1-C4烷基-S(O)n—,其中n为0,1或2,硝基,乙酰基,—CF3,—SCF3和氰基; Z选择自H,OR3或F,其中R3选择自H,C1-C6烷基和苯基C1C6烷基; R1和R2各自独立地选择自H或C1-C4烷基;以及其药学上可接受的盐。
    公开号:
    US07410982B2
点击查看最新优质反应信息

文献信息

  • [EN] 3-ARYLOXY/ THIO-2, 3-SUBSTITUTED PROPANAMINES AND THEIR USE IN INHIBITING SEROTONIN AND NOREPINEPHRINE REUPTAKE<br/>[FR] 3-ARYLOXY/THIO-2, 3-SUBSTITUE PROPANAMINES ET LEUR UTILISATION POUR INHIBER LE RECAPTAGE DE LA SEROTONINE ET DE LA NOREPINEPHRINE
    申请人:LILLY CO ELI
    公开号:WO2004043903A1
    公开(公告)日:2004-05-27
    There is provided a compound of formula (I) wherein A is selected from -O- and -S-; X is selected from phenyl optionally substituted with up to 5 substituents each independently selected from halo, C1-C4 alkyl and C1-C4 alkoxy, thienyl optionally substituted with up to 3 substituents each independently selected from halo and C1-C4 alkyl, and C2-C8 alkyl, C2-C8 alkenyl, C3-C8 cycloalkyl and C4-C8 cycloalkylalkyl, each of which may be optionally substituted with up to 3 substituents each independently selected from halo, C1-C4 alkyl, C1-C4 alkoxy, C1-C4 alkyl-S(O)n- where n is 0, 1 or 2, -CF3, -CN and -CONH2; Y is selected from phenyl, naphthyl, dihydrobenzothienyl, benzothiazolyl, benzoisothiazolyl, quinolyl, isoquinolyl, naphthyridyl, thienopyridyl, indanyl, 1,3-benzodioxolyl, benzothienyl, indolyl and benzofuranyl, each of which may be optionally substituted with up to 4 or, where possible, up to 5 substituents each independently selected from halo, C1-C4 alkyl, C1-C4 alkoxy, C1-C4 alkyl-S(O)n- where n is 0, 1 or 2, nitro, acetyl, -CF3, -SCF3 and cyano; and when Y is indolyl it may be substituted or further substituted by an N-substituent selected from C1-C4 alkyl; Z is selected from OR3 or F, wherein R3 is selected from H, C1-C6 alkyl and phenyl C1-C6 alkyl; R1 and R2 are each independently H or C1-C4 alkyl; and pharmaceutically acceptable salts thereofwith the proviso that when Y is optionally substituted phenyl or optionally substituted 1,3-benzodioxolyl and Z is OR3 and X is optionally substituted phenyl then A is -S-.
    提供一种化合物,其化学式为(I),其中A从-O-和-S-中选择;X从苯基选项地取代,每个取代基可独立地从卤素、C1-C4烷基和C1-C4烷氧基中选择最多5个取代基,噻吩基选项地取代,每个取代基可独立地从卤素和C1-C4烷基中选择最多3个取代基,以及C2-C8烷基、C2-C8烯基、C3-C8环烷基和C4-C8环烷基烷基,每个基可选地取代,每个取代基可独立地从卤素、C1-C4烷基、C1-C4烷氧基、C1-C4烷基-S(O)n-(其中n为0、1或2)、-CF3、-CN和-CONH2中选择;Y从苯基、基、二氢苯并噻吩基、苯并噻唑基、苯并异噻唑基、喹啉基、异喹啉基、啉基、噻吩吡啉基、基、1,3-苯并二氧杂环戊基、苯并噻吩基、吲哚基和苯并呋喃基中选择,每个基可选地取代,最多可独立地从卤素、C1-C4烷基、C1-C4烷氧基、C1-C4烷基-S(O)n-(其中n为0、1或2)、硝基、乙酰基、- 、-S 和基中选择最多4个或在可能的情况下最多5个取代基;当Y为吲哚基时,它可以被取代或进一步被N-取代基取代,N-取代基从C1-C4烷基中选择;Z从OR3或F中选择,其中R3从H、C1-C6烷基和苯基C1-C6烷基中选择;R1和R2各自独立地为H或C1-C4烷基;以及其药学上可接受的盐,但有一个条件,即当Y为可选地取代的苯基或可选地取代的1,3-苯并二氧杂环戊基,Z为OR3且X为可选地取代的苯基时,A为-S-。
  • [EN] 3-ARYLOXY/THIO-3-SUBSTITUTED PROPANAMINES AND THEIR USE IN INHIBITING SEROTONIN AND NOREPHINEPHRINE REUPTAKE<br/>[FR] COMPOSES PHARMACEUTIQUES
    申请人:LILLY CO ELI
    公开号:WO2004043904A1
    公开(公告)日:2004-05-27
    There is provided a compound of formula (I) wherein A is selected from -O- and -S-; X is selected from C2-C8 alkyl, C2-C8 alkenyl, C3-C8 cycloalkyl and C4-C8 cycloalkylalkyl, each of which may be optionally substituted with up to 3 substituents each independently selected from halo, C1-C4 alkyl, C1-C4 alkoxy, C1-C4 alkyl-S(O)n- where n is 0, 1 or 2, -CF3, -CN and -CONH2; Y is selected from phenyl, naphthyl, dihydrobenzothienyl, benzothiazolyl, benzoisothiazolyl, quinolyl, isoquinolyl, naphthyridyl, thienopyridyl, indanyl, 1,3-benzodioxolyl, benzothienyl, indolyl and benzofuranyl, each of which may be optionally substituted with up to 4 or, where possible, 5 substituents each independently selected from halo, C1-C4 alkyl, C1-C4 alkoxy, C1-C4 alkyl-S(O)n- where n is 0, 1 or 2, nitro, acetyl, -CF3, -SCF3 and cyano; and when Y is indolyl it may be substituted or further substituted by an N-substituent selected from C1-C4 alkyl; Z is selected from H, OR3 or F, wherein R3 is selected from H, C1-C6 alkyl and phenyl C1-C6 alkyl; R1 and R2 are each independently H or C1-C4 alkyl; with the proviso that, when Z is H, then Y may not be optionally substituted phenyl or optionally substituted naphthyl.
    提供一种具有以下结构的化合物(I):其中A从-O-和-S-中选择;X从C2-C8烷基,C2-C8烯基,C3-C8环烷基和C4-C8环烷基烷基中选择,每种基团可能分别被选自卤素,C1-C4烷基,C1-C4烷氧基,C1-C4烷基-S(O)n-(其中n为0,1或2),-CF3,-CN和-CONH2的最多3个取代基所取代;Y从苯基,基,二氢苯并噻吩基,苯并噻唑基,苯并异噻唑基,喹啉基,异喹啉基,啉基,噻吩吡啉基,基,1,3-苯并二氧杂环戊基,苯并噻吩基,吲哚基和苯并呋喃基中选择,每种基团可能分别被选自卤素,C1-C4烷基,C1-C4烷氧基,C1-C4烷基-S(O)n-(其中n为0,1或2),硝基,乙酰基,- ,-S 和基的最多4个或在可能的情况下5个取代基所取代;当Y为吲哚基时,它可以被选自C1-C4烷基的N-取代基取代或进一步取代;Z从H,OR3或F中选择,其中R3从H,C1-C6烷基和苯基C1-C6烷基中选择;R1和R2分别独立地为H或C1-C4烷基;但是,当Z为H时,Y可能不是可选择地取代的苯基或可选择地取代的基。
  • [EN] PROPANAMINE DERIVATIVES AS SEROTONIN AND NOREPINEPHRINE REUPTAKE INHIBITORS<br/>[FR] DERIVES DE PROPANAMINE UTILISES EN TANT QU'INIHIBITEURS DU RECAPTAGE DE LA SEROTONINE ET DE LA NOREPINEPHRINE
    申请人:LILLY CO ELI
    公开号:WO2004043931A1
    公开(公告)日:2004-05-27
    There is provided a heretoaryloxy/thio 3-substituted propanamine compound of formula (I) wherein A is selected from -O- and -S-; X is selected from phenyl optionally substituted with up to 5 substituents each independently selected from halo, C1-C4 alkyl and C1-C4 alkoxy, thienyl optionally substituted with up to 3 substituents each independently selected from halo and C1-C4 alkyl, and C2-C8 alkyl, C2-C8 alkenyl, C3-C8 cycloalkyl and C4-C8 cycloalkylalkyl, each of which may be optionally substituted with up to 3 substituents each independently selected from halo, C1-C4 alkyl, C1-C4 alkoxy, C1-C4 alkyl-S(O)n- where n is 0, 1 or 2, -CF3, -CN and -CONH2; Y is selected from dihydrobenzothienyl, benzothiazolyl, benzoisothiazolyl, quinolyl, isoquinolyl, naphthyridyl, and thienopyridyl, each of which may be optionally substituted with up to 4 or, where possible, up to 5 substituents each independently selected from halo, C1-C4 alkyl, C1-C4 alkoxy, C1-C4 alkyl-S(O)n- where n is 0, 1 or 2, nitro, acetyl, -CF3, -SCF3 and cyano; Z is selected from H, OR3 or F, wherein R3 is selected from H, C1-C6 alkyl and phenyl C1-C6 alkyl; R1 and R2 are each independently H or C1-C4 alkyl; and pharmaceutically acceptable salts thereof.
    提供了一种公式(I)的醚/代3-取代丙胺化合物,其中A选自-O-和-S-;X选自苯基,可选地取代为最多5个取代基,每个取代基独立选自卤素、C1-C4烷基和C1-C4烷氧基,噻吩基,可选地取代为最多3个取代基,每个取代基独立选自卤素和C1-C4烷基,以及C2-C8烷基,C2-C8烯基,C3-C8环烷基和C4-C8环烷基烷基,每个基可选地取代为最多3个取代基,每个取代基独立选自卤素、C1-C4烷基、C1-C4烷氧基、C1-C4烷基-S(O)n-其中n为0、1或2、-CF3、-CN和-CONH2;Y选自二氢苯并噻吩基,苯并噻唑基,苯并异噻唑基,喹啉基,异喹啉基,啉基和噻吩吡啉基,每个基可选地取代为最多4个或在可能的情况下,最多5个取代基,每个取代基独立选自卤素、C1-C4烷基、C1-C4烷氧基、C1-C4烷基-S(O)n-其中n为0、1或2、硝基、乙酰基、- 、-S 和基;Z选自H、OR3或F,其中R3选自H、C1-C6烷基和苯基C1-C6烷基;R1和R2各自独立地为H或C1-C4烷基;以及其药学上可接受的盐。
  • 3-Aryloxy/thio-3-substituted propanamines and their use in inhibiting serotonin and norephinephrine reuptake
    申请人:Boulet Louis Serge
    公开号:US20060014779A1
    公开(公告)日:2006-01-19
    There is provided a compound of formula (I) wherein A is selected from —O— and —S—; X is selected from C 2 -C 8 alkyl, C 2 -C 8 alkenyl, C 3 -C 8 cycloalkyl and C 4 -C 8 cycloalkylalkyl, each of which may be optionally substituted with up to 3 substituents each independently selected from halo, C 1 -C 4 alkyl, C 1 -C 4 alkoxy, C 1 -C 4 alkyl-S(O) n — where n is 0, 1 or 2 , —CF 3 , —CN and —CONH 2 ; Y is selected from phenyl, naphthyl, dihydrobenzothienyl, benzothiazolyl, benzoisothiazolyl, quinolyl, isoquinolyl, naphthyridyl, thienopyridyl, indanyl, 1,3 -benzodioxolyl, benzothienyl, indolyl and benzofuranyl, each of which may be optionally substituted with up to 4 or, where possible, 5 substituents each independently selected from halo, C 1 -C 4 alkyl, C 1 -C 4 alkoxy, C 1 -C 4 alkyl-S(O) n — where n is 0, 1 or 2 , nitro, acetyl, —CF 3 , —SCF 3 and cyano; and when Y is indolyl it may be substituted or further substituted by an N-substituent selected from C 1 -C 4 alkyl; Z is selected from H, OR 3 or F, wherein R 3 is selected from H, C 1 -C 6 alkyl and phenyl C 1 -C 6 alkyl; R 1 and R 2 are each independently H or C 1 -C 4 alkyl; with the proviso that, when Z is H, then Y may not be optionally substituted phenyl or optionally substituted naphthyl.
    提供了一种化合物,其化学式为(I),其中A从—O—和—S—中选择;X从C2-C8烷基,C2-C8烯基,C3-C8环烷基和C4-C8环烷基烷基中选择,每种基团均可选用最多3个取代基,每个取代基可独立地从,C1-C4烷基,C1-C4烷氧基,C1-C4烷基-S(O)n-其中n为0,1或2,—CF3,—CN和—CONH2中选择;Y从苯基,基,二氢苯并噻吩基,苯并噻唑基,苯并异噻唑基,喹啉基,异喹啉基,啉基,噻吩基,基,1,3-苯并二氧杂环基,苯并噻吩基,吲哚基和苯并呋喃基中选择,每种基团均可选用最多4个或在可能的情况下最多5个取代基,每个取代基可独立地从,C1-C4烷基,C1-C4烷氧基,C1-C4烷基-S(O)n-其中n为0,1或2,硝基,乙酰基,— ,—S 和基中选择;当Y为吲哚基时,它可以被一个N-取代基所取代,所述取代基从C1-C4烷基中选择;Z从H,OR3或F中选择,其中R3从H,C1-C6烷基和苯基C1-C6烷基中选择;R1和R2各自独立地为H或C1-C4烷基;但是,当Z为H时,Y可能不是可选取代的苯基或可选取代的基。
  • 3-aryloxy/thio-3-substituted propanamines and their use in inhibiting serotonin and norepinephrine reuptake
    申请人:Eli Lilly and Company
    公开号:US07417064B2
    公开(公告)日:2008-08-26
    There is provided a compound of formula (I) wherein A is selected from —O— and —S—; X is selected from C2-C8 alkyl, C2-C8 alkenyl, C3-C8 cycloalkyl and C4-C8 cycloalkylalkyl, each of which may be optionally substituted with up to 3 substituents each independently selected from halo, C1-C4 alkyl, C1-C4 alkoxy, C1-C4 alkyl-S(O)n— where n is 0, 1 or 2, —CF3, —CN and —CONH2; Y is selected from phenyl, naphthyl, dihydrobenzothienyl, benzothiazolyl, benzoisothiazolyl, quinolyl, isoquinolyl, naphthyridyl, thienopyridyl, indanyl, 1,3-benzodioxolyl, benzothienyl, indolyl and benzofuranyl, each of which may be optionally substituted with up to 4 or, where possible, 5 substituents each independently selected from halo, C1-C4 alkyl, C1-C4 alkoxy, C1-C4 alkyl-S(O)n— where n is 0, 1 or 2, nitro, acetyl, —CF3, —SCF3 and cyano; and when Y is indolyl it may be substituted or further substituted by an N-substituent selected from C1-C4 alkyl; Z is selected from H, OR3 or F, wherein R3 is selected from H, C1-C6 alkyl and phenyl C1-C6 alkyl; R1 and R2 are each independently H or C1-C4 alkyl; with the proviso that, when Z is H, then Y may not be optionally substituted phenyl or optionally substituted naphthyl.
    提供了一个化合物的公式(I),其中A从- O-和-S-中选择;X从C2-C8烷基,C2-C8烯基,C3-C8环烷基和C4-C8环烷基烷基中选择,每个基团都可以选择性地取代高达3个取代基,每个取代基都是独立选择的,从卤素,C1-C4烷基,C1-C4烷氧基,C1-C4烷基-S(O)n-其中n为0,1或2,-CF3,-CN和-CONH2; Y从苯,,二氢苯并噻吩基,苯并噻唑基,苯并异噻唑基,喹啉基,异喹啉基,啉基,噻吩基,基,1,3-苯并二氧杂环基,苯并噻吩基,吲哚基和苯并呋喃基中选择,每个基团都可以选择性地取代高达4个或,在可能的情况下,5个取代基,每个取代基都是独立选择的,从卤素,C1-C4烷基,C1-C4烷氧基,C1-C4烷基-S(O)n-其中n为0,1或2,硝基,乙酰基,- ,-S 和基;当Y是吲哚基时,它可以被取代或进一步取代一个N-取代基,该取代基选择自C1-C4烷基; Z从H,OR3或F中选择,其中R3从H,C1-C6烷基和苯基C1-C6烷基中选择; R1和R2各自独立地是H或C1-C4烷基;前提是,当Z是H时,Y不能是选择性地取代的苯基或选择性地取代的基。
查看更多

同类化合物

肼甲硫代酰胺,2-(7-氯-2,3-二氢-1,5-苯并硫氮杂卓-4(5H)-亚基)- 美替克仑 硫代苯并二氢吡喃-3-酮 硫代苯并二氢吡喃-3-胺盐酸盐 硫代苯并二氢吡喃-3-胺 硫代色满-4-酮 硫代色满 硫代-3,4-二氢苯并吡喃-4-醇 盐酸特他洛尔 他扎罗汀酸亚砜 N-叔-丁基-3-(3,4-二氢-2H-硫代色烯-8-氧基)-2-甲氧基丙烷-1-胺乙二酸酯 N-(3,4-二氢-4-氧代-2H-1-苯并噻喃-6-基)乙酰胺 8-甲氧基硫代色满-3-胺盐酸盐 8-甲氧基硫代色满-3-胺 8-氯-3,4-二氢-5-甲氧基-4-氧代-2H-1-苯并噻喃-2-乙酸 8-氟-2,3-二氢-4H-硫代色烯-4-酮 8-[3-[叔丁基氨基]-2-羟基丙氧基]-3,4-二氢-2H-1-苯并噻喃-4-醇 7-甲氧基硫代苯并二氢吡喃-4-酮 7-甲氧基硫代色满-3-胺 7-溴硫代苯并二氢吡喃-4-酮 6-硝基硫代苯并二氢吡喃-4-酮 6-甲氧基硫代苯并二氢吡喃-3-胺 6-甲基硫代苯并二氢吡喃-4-酮 6-甲基硫代色满 6-甲基-3,4-二氢-2H-苯并噻喃1,1-二氧化物 6-甲基-1,1-二氧代-3,4-二氢-2H-苯并噻喃-7-磺酰氯 6-溴硫代苯并二氢吡喃-4-酮 6-溴硫代苯并二氢吡喃-3-胺 6-溴-4,4-二甲基硫代苯并二氢吡喃 6-溴-3,4-二氢-2H-S,S-二-氧代-硫代色烯-4-胺盐酸盐 6-溴-3,4-二氢-2H-1-苯并噻喃-4-胺盐酸盐 6-溴-2,3-二氢硫代色烯-1,1-二氧化物-4-酮 6-氯硫代苯并二氢吡喃-4-酮 6-氯-2-甲基-3,4-二氢-2H-1-苯并噻因-4-酮 6-氯-2-甲基(硫苯并二氢吡喃-4-酮)-1,1-二氧化物 6-氯-1-苯并硫代吡喃-4-酮 1,1-二氧化物 6-氨基硫代苯并二氢吡喃-4-酮 6-氟硫代苯并二氢吡喃-3-胺 6-氟硫代-4-色原酮 6-乙酰基-4,4-二甲基二氢苯并噻喃 6-乙炔基-4,4-二甲基二氢苯并噻喃 6-[2-(3,4-二氢-4,4-二甲基-2H-1-苯并噻喃-6-基)乙炔基]-3-吡啶甲酸 6,7-二氟-2,3-二氢-4H-1-苯并噻喃-4-酮 5-甲氧基硫代苯并二氢吡喃-3-胺 5-(硫代色满-8-基氧基甲基)-1,3-恶唑烷-2-酮 5-(3,4-二氢-2H-硫代色烯-4-基)嘧啶-4(3H)-酮 4-氨基-6-溴-3,4-二氢-2H-s,s-二氧代-硫代色烯盐酸盐 4-氧代硫代苯并二氢吡喃-2-羧酸 4-(甲基)硫代色满-4-醇 4,4-二甲基硫代苯并二氢吡喃-6-甲醛